Immunotherapy Company Will Present Findings at the JP Morgan Healthcare Conference in San Francisco on January 7th Second Round Crossover Funding...
CELGENE MAKES LANDMARK INVESTMENT IN NANTHEALTH TO ADVANCE GROUNDBREAKING CANCER RESEARCH FOR PATIENTS $25 Million Investment Advances Celgene’s Strategic Collaboration...